Sofosbuvir / Ledipasvir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Sofosbuvir 400 mg & Ledipasvir 90 mg
Reference Brands: Harvoni®(EU & US)
Category: Anti Viral
Sofosbuvir & Ledipasvir Tablets (400/90 mg) treat Hepatitis C with high cure rates. Available under brands like Harvoni®, Ledifos®, and Hepcinat-LP®, they can be bulk-sourced via PharmaB2B platforms from WHO-GMP-approved manufacturers for tenders, NGOs, and HCV treatment programs worldwide.
Product Description:
Sofosbuvir & Ledipasvir Tablets (400 mg/90 mg) are a powerful, once-daily combination therapy for chronic Hepatitis C. Marketed under global brands like Harvoni®, Ledifos®, and Hepcinat-LP®, this fixed-dose antiviral regimen is recommended by WHO and major liver associations. It offers high cure rates with minimal side effects across genotypes 1, 4, 5, and 6. On PharmaB2B platforms, global buyers can source WHO-GMP and USFDA-approved generic alternatives from trusted Indian manufacturers. Ideal for institutional procurement, NGO supply, and public health programs, Sofosbuvir + Ledipasvir helps scale access to life-saving HCV treatment worldwide.
Sofosbuvir / Ledipasvir — third party manufacturing & bulk supply
Sofosbuvir / Ledipasvir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Sofosbuvir / Ledipasvir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Sofosbuvir / Ledipasvir →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sofosbuvir & Ledipasvir is used for the treatment of chronic hepatitis C virus (HCV) infection, mainly genotype 1, 4, 5, and 6. It helps reduce viral load and supports complete viral clearance with sustained virologic response.
It is made from the active ingredients sofosbuvir, an NS5B polymerase inhibitor, and ledipasvir, an NS5A inhibitor. Together they block HCV replication and viral assembly.
The primary trade name is Harvoni in the USA, EU, and UK, along with multiple licensed generics available in India and other regions.
Harvoni is manufactured by Gilead Sciences. Several licensed generic manufacturers in India and other countries also produce approved generic versions.
The generic name is sofosbuvir & ledipasvir.
The main brand name is Harvoni, with various licensed generic brand names depending on the region.
It is manufactured by Gilead Sciences in the USA and by licensed generic manufacturers in India and other global regions.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
